Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Recruiting · NCT05753930 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Imlifidase Prior to Kidney Transplant in Highly Sensitised Children | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 2 | 2026-08-18 | NCT05753930 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hansa Biopharma AB | 4 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Great Ormond Street Hospital For Children Nhs Foundation Trust | London | United Kingdom | 23 |
| Hospital Sant Joan De Deu Barcelona | Barcelona | Spain | 2 |
| Hospital Unviersitari Vall d'Hebron, Nefrología Pediátrica | Barcelona | Spain | 1 |
| HUS, Helsinki University Hospital | Helsinki | Finland | 1 |
| Karolinska University Hospital | Huddinge | Sweden | 1 |
| Robert Debre University Hospital | Paris | France | 3 |